Detalhe da pesquisa
1.
Ten quick tips for building FAIR workflows.
PLoS Comput Biol
; 19(9): e1011369, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37768885
2.
M-protein diagnostics in multiple myeloma patients using ultra-sensitive targeted mass spectrometry and an off-the-shelf calibrator.
Clin Chem Lab Med
; 62(3): 540-550, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37823394
3.
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma.
Clin Chem Lab Med
; 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332688
4.
The GlycoPaSER Prototype as a Real-Time N-Glycopeptide Identification Tool Based on the PaSER Parallel Computing Platform.
Int J Mol Sci
; 24(9)2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175577
5.
Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studies.
BMC Genomics
; 23(1): 546, 2022 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35907790
6.
Site-Specific, Platform-Based Conjugation Strategy for the Synthesis of Dual-Labeled Immunoconjugates for Bimodal PET/NIRF Imaging of HER2-Positive Tumors.
Bioconjug Chem
; 33(3): 530-540, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230093
7.
Primary Focal Segmental Glomerulosclerosis Plasmas Increase Lipid Droplet Formation and Perilipin-2 Expression in Human Podocytes.
Int J Mol Sci
; 24(1)2022 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36613637
8.
Clonotypic Features of Rearranged Immunoglobulin Genes Yield Personalized Biomarkers for Minimal Residual Disease Monitoring in Multiple Myeloma.
Clin Chem
; 67(6): 867-875, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709101
9.
Multiple Myeloma Minimal Residual Disease Detection: Targeted Mass Spectrometry in Blood vs Next-Generation Sequencing in Bone Marrow.
Clin Chem
; 67(12): 1689-1698, 2021 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643690
10.
Affimers as an alternative to antibodies for protein biomarker enrichment.
Protein Expr Purif
; 174: 105677, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32461183
11.
Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonisms.
BMC Neurol
; 20(1): 26, 2020 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-31952511
12.
Evaluation of chitotriosidase as a biomarker for adipose tissue inflammation in overweight individuals and type 2 diabetic patients.
Int J Obes (Lond)
; 43(9): 1712-1723, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30301968
13.
The future of protein biomarker research in type 2 diabetes mellitus.
Expert Rev Proteomics
; 16(2): 105-115, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30468403
14.
Clinical biomarker innovation: when is it worthwhile?
Clin Chem Lab Med
; 57(11): 1712-1720, 2019 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31287794
15.
A multi-omics data analysis workflow packaged as a FAIR Digital Object.
Gigascience
; 132024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38217405
16.
Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
J Adv Res
; 2023 Sep 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683725
17.
Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study.
J Clin Endocrinol Metab
; 108(6): 1387-1393, 2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36533509
18.
Impact of infection on proteome-wide glycosylation revealed by distinct signatures for bacterial and viral pathogens.
iScience
; 26(8): 107257, 2023 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37520696
19.
The proteomic toolbox for studying cerebrospinal fluid.
Expert Rev Proteomics
; 9(2): 165-79, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22462788
20.
Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
Mol Cell Proteomics
; 9(9): 2063-75, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20811074